The 2020 Congress of the International Society of Thrombosis and Haemostasis (ISTH)
was held virtually July 12-15, 2019, due to the coronavirus disease 2019 pandemic.
The congress convenes annually to discuss clinical and basic topics in hemostasis
and thrombosis. Each year, the program includes State of Art (SOA) lectures given
by prominent scientists. Presenters are asked to create Illustrated Capsules of their
talks, which are concise illustrations with minimal explanatory text. Capsules cover
major themes of the presentation, and these undergo formal peer review for inclusion
in this article. Owing to the shift to a virtual congress this year, organizers reduced
the program size. There were 39 SOA lectures virtually presented, and 29 capsules
(9 from talks omitted from the virtual congress) were both submitted and successful
in peer review, and are included in this article. Topics include the roles of the
hemostatic system in inflammation, infection, immunity, and cancer, platelet function
and signaling, platelet function disorders, megakaryocyte biology, hemophilia including
gene therapy, phenotype tests in hemostasis, von Willebrand factor, anticoagulant
factor V, computational driven discovery, endothelium, clinical and basic aspects
of thrombotic microangiopathies, fibrinolysis and thrombolysis, antithrombotics in
pediatrics, direct oral anticoagulant management, and thrombosis and hemostasis in
pregnancy. Capsule authors invite virtual congress attendees to refer to these capsules
during the live presentations and participate on Twitter in discussion. Research and
Practice in Haemostasis and Thrombosis will release 2 tweets from @RPTHJournal during
each presentation, using #IllustratedReview, #CoagCapsule and #ISTH2020. Readers are
also welcome to utilize capsules for teaching and ongoing education.
